Efficacy of Tiotropium Bromide combined with Budesonide Formoterol in the treatment of chronic obstructive pulmonary disease
ZHU Yu-jun1 LIANG Qiu-hong2
1.Department of Respiratory,Yichun People′s Hospital,Jiangxi Province,Yichun 336000,China;2.Department of Infection,the Second People′s Hospital of Yichun City,Jiangxi Province,Yichun 336000,China
Abstract: Objective To investigate the efficacy of Tiotropium Bromide combined with Budesonide Formoterol in the treatment of chronic obstructive pulmonary disease (COPD).Methods A total of 88 patients with stable COPD admitted to Yichun People′s Hospital from January 2019 to January 2020 were selected and divided into two groups according to random number table method,44 cases in each group.The control group was treated with Budesonide Formoterol,and the observation group was treated with Tiotropium Bromide on the basis of the control group.The clinical efficacy,pulmonary function and adverse reactions were compared between the two groups.Results The total effective rate of the observation group was higher than that in the control group,the difference was statistically significant (P<0.05).Forced expiratory volumone second (FEV1),forced vital capacity (FVC),FEV1/FVC,interleukin-6 (IL-6),tissue inhibitor of metalloproteinase-1 (TIMP-1) and transforming growth factor-β (TGF-β) between two groups before treatment were compared,the differences had no statistically significant (P>0.05).After treatment 3 months,in the observation group,FEV1 was (2.71±0.45) mL,FVC was (3.11±0.39) mL,FEV1/FVC was (72.34±6.55)%,which were higher than those in the control of (2.26±0.43) mL,(2.57±0.19) mL,(62.21±7.51)%,after treatment 3 months,in the observation group,IL-6 was (15.06±6.03) ng/mL,TIMP-1 was (120.25±32.82) ng/mL,TGF-β was (79.54±9.24) ng/L,which were lower than those in the control group of (21.68±7.41) ng/mL,(145.11±33.18)ng/mL,(87.25±9.72) ng/L,the differences were statistically significant (P<0.05).There was significant difference in the total incidence of adverse reactions between the two groups(P>0.05).Conclusion Tiotropium Bromide combined with Budesonide Formoterol is effective in the treatment of COPD.It can improve the lung function and has high safety.It can be used as a safe and effective treatment for COPD patients.